Indacaterol/glycopyrrolate Significantly Improves COPD Assessment Test (cat) Scores In Us Patients With Moderate-To-Severe COPD: Subgroup Analysis From Pooled Flight1 And Flight2 Studies

被引：0
|
作者：
Fogel, R. [1 ]
Maitra, S. [2 ]
Patalano, F. [3 ]
Banerji, D. [1 ]
机构：
[1] Novartis Pharmaceut, E Hanover, NJ USA
[2] Novartis Healthcare Pvt Ltd, Hyderabad, Andhra Pradesh, India
[3] Novartis Pharma AG, Basel, Switzerland
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2016年 / 193卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A6801
引用
收藏
页数：1
相关论文
共 46 条
  • [31] Efficacy Of Inhaled Glycopyrrolate For Moderate-To-Severe COPD: A Subgroup Analysis By Gender From The Pooled Gem1 And Gem2 Studies
    Mahler, D. A.
    Satti, A.
    Spangenthal, S.
    Yadao, A.
    D'Andrea, P.
    Uddin, A.
    Franke-Bray, B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [32] Safety Of Inhaled Glycopyrrolate In Patients With Moderate-To-Severe COPD: Subgroup Analysis From The Pooled Data Of Four Clinical Trials
    D'Andrea, P.
    LaForce, C.
    Pedinoff, A.
    Miller, S.
    Yadao, A.
    Uddin, A.
    Franke-Bray, B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [33] Qva149 Improves Lung Function To A Greater Extent Than Monocomponents In Patients With Moderate-To-Severe COPD: The Flight1 Study
    Kerwin, E. M.
    FowlerTaylor, A.
    Ayers, T.
    Thach, C.
    Maitra, S.
    Patalano, F.
    Banerji, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [34] Improvement In Lung Function With Twice-Daily Indacaterol/glycopyrrolate Versus Once-Daily Indacaterol In Patients With Moderate-To-Severe COPD: Results From The Flight3 Study
    Mahler, D. A.
    Ferguson, G. T.
    Fucile, S.
    Yadao, A.
    Wang, Q.
    Ayers, T.
    Fogel, R.
    Patalano, F.
    Banerji, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [35] Safety Of Qva149 Versus Its Monocomponents And Placebo: A Pooled Safety Analysis From Flight1 And Flight2 Studies
    FowlerTaylor, A.
    Ayers, T.
    Thach, C.
    Patalano, F.
    Schubert-Tennigkeit, A. A.
    Banerji, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [36] Qva149 Reduces Dyspnea In Patients With Moderate-To-Severe COPD As Measured By The Transition Dyspnea Index: The Flight2 Study
    Mahler, D. A.
    Ayers, T.
    FowlerTaylor, A.
    Larbig, M.
    Thach, C.
    Maitra, S.
    Patalano, F.
    Banerji, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [37] Qva149 Provides Superior Improvement In Lung Function Versus Its Monocomponents In Patients With Moderate-To-Severe COPD: The Flight2 Study
    Kerwin, E. M.
    Ayers, T.
    FowlerTaylor, A.
    Larbig, M.
    Thach, C.
    Maitra, S.
    Patalano, F.
    Banerji, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [38] QVA149 Demonstrated Significant Improvement in Lung Function Compared With Placebo and Its Monocomponents: Pooled Analysis From the FLIGHT1 and FLIGHT2 Studies
    Kerwin, Edward
    Ayers, Tim
    FowlerTaylor, Angel
    Patalano, Francesco
    Banerji, Donald
    Maitra, Samopriyo
    CHEST, 2015, 148 (04)
  • [39] Qva149 Demonstrates Superior Improvements In Health Status, As Measured By Sgrq, Compared With Placebo In Patients With Moderate-To-Severe COPD: The Flight2 Study
    Jones, P. W.
    Ayers, T.
    FowlerTaylor, A.
    Larbig, M.
    Thach, C.
    Maitra, S.
    Patalano, F.
    Banerji, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [40] Effect of Metabolic Syndrome Status on Lung Function and Patient- reported Outcomes in Patients with Chronic Obstructive Pulmonary Disease (COPD) Receiving Indacaterol/Glycopyrrolate: Co-morbidity Analysis of the Phase 3 FLIGHT1 and 2 Studies
    Carlin, Brian
    Ferguson, Gary T.
    Sanjar, Shahin
    Sharma, Sanjay
    Ozol-Godfrey, Ayca
    Goodin, Thomas
    CIRCULATION, 2018, 138
12345